Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (vol 96, pg 1307, 2018)

被引:1
|
作者
Lin, Wei-Chou [1 ]
Hsu, Fu-Shun [2 ,3 ]
Kuo, Kuan-Lin [4 ,5 ]
Liu, Shing-Hwa [4 ]
Shun, Chia-Tung [1 ]
Shi, Chung-Sheng [6 ]
Chang, Hong-Chiang [5 ]
Tsai, Yu-Chieh [7 ]
Lin, Ming-Chieh [8 ]
Wu, June-Tai [8 ]
Kuo, Yu [8 ,9 ]
Chow, Po-Ming [5 ]
Liao, Shih-Ming [5 ]
Yang, Shao-Ping [5 ]
Hong, Jo-Yu [5 ]
Huang, Kuo-How [5 ,10 ]
机构
[1] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Pathol, Coll Med, Taipei, Taiwan
[2] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan
[3] New Taipei City Hosp, Dept Urol, New Taipei, Taiwan
[4] Natl Taiwan Univ, Grad Inst Toxicol, Coll Med, Taipei, Taiwan
[5] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Urol, Coll Med, Taipei, Taiwan
[6] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan
[7] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Oncol, Coll Med, Taipei, Taiwan
[8] Natl Taiwan Univ, Grad Inst Mol Med, Coll Med, Taipei, Taiwan
[9] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan
[10] Natl Taiwan Univ, Dept Urol, Coll Med, 1 Jen Ai Rd, Taipei 10051, Taiwan
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2019年 / 97卷 / 03期
关键词
D O I
10.1007/s00109-019-01748-2
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In Fig. 1b, upper part, the cell viability counts after treatment with cisplatin and TSA in T24 cells was by mistake a duplication of the image for NTUB1 on the left. In the corrected version of Fig. 1, the image was replaced appropriately.
引用
收藏
页码:435 / 436
页数:2
相关论文
共 8 条
  • [1] Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
    Lin, Wei-Chou
    Hsu, Fu-Shun
    Kuo, Kuan-Lin
    Liu, Shing-Hwa
    Shun, Chia-Tung
    Shi, Chung-Sheng
    Chang, Hong-Chiang
    Tsai, Yu-Chieh
    Lin, Ming-Chieh
    Wu, June-Tai
    Kuo, Yu
    Chow, Po-Ming
    Liao, Shih-Ming
    Yang, Shao-Ping
    Hong, Jo-Yu
    Huang, Kuo-How
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2018, 96 (12): : 1307 - 1318
  • [2] Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
    Wei-Chou Lin
    Fu-Shun Hsu
    Kuan-Lin Kuo
    Shing-Hwa Liu
    Chia-Tung Shun
    Chung-Sheng Shi
    Hong-Chiang Chang
    Yu-Chieh Tsai
    Ming-Chieh Lin
    June-Tai Wu
    Yu Kuo
    Po-Ming Chow
    Shih-Ming Liao
    Shao-Ping Yang
    Jo-Yu Hong
    Kuo-How Huang
    Journal of Molecular Medicine, 2018, 96 : 1307 - 1318
  • [3] Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
    Wei-Chou Lin
    Fu-Shun Hsu
    Kuan-Lin Kuo
    Shing-Hwa Liu
    Chia-Tung Shun
    Chung-Sheng Shi
    Hong-Chiang Chang
    Yu-Chieh Tsai
    Ming-Chieh Lin
    June-Tai Wu
    Yu Kuo
    Po-Ming Chow
    Shih-Ming Liao
    Shao-Ping Yang
    Jo-Yu Hong
    Kuo-How Huang
    Journal of Molecular Medicine, 2019, 97 : 435 - 436
  • [4] Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway
    Hsu, Fu-Shun
    Wu, June-Tai
    Lin, Jing-Yi
    Yang, Shao-Ping
    Kuo, Kuan-Lin
    Lin, Wei-Chou
    Shi, Chung-Sheng
    Chow, Po-Ming
    Liao, Shih-Ming
    Pan, Chun-I
    Hong, Jo-Yu
    Chang, Hong-Chiang
    Huang, Kuo-How
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (05):
  • [5] Histone deacetylase inhibitor trichostatin A resensitizes gemcitabine resistant urothelial carcinoma cells via suppression of TG-interacting factor
    Yeh, Bi-Wen
    Li, Wei-Ming
    Li, Ching-Chia
    Kang, Wan-Yi
    Huang, Chun-Nung
    Hour, Tzyh-Chyuan
    Liu, Zi-Miao
    Wu, Wen-Jeng
    Huang, Huei-Sheng
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2016, 290 : 98 - 106
  • [6] RETRACTION: Evodiamine Induces Apoptosis, G2/M Cell Cycle Arrest, and Inhibition of Cell Migration and Invasion in Human Osteosarcoma Cells via Raf/MEK/ERK Signalling Pathway (Retraction of Vol 24, Pg 5874, 2018)
    Zhou, Yuelai
    Hu, Jinlong
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [7] RETRACTION: Knockdown of Fibrous Sheath Interacting Protein 1 Expression Reduces Bladder Urothelial Carcinoma Cell Proliferation and Induces Apoptosis via Inhibition of the PI3K/AKT Pathway (vol 11, pg 1961, 2018) (Retraction of Vol 11, Pg 1961, 2018)
    Sun, M.
    Chen, Z.
    Tan, S.
    Liu, C.
    Zhao, W.
    ONCOTARGETS AND THERAPY, 2022, 15 : 85 - 85
  • [8] Novel 2-phenyloxypyrimidine derivative induces apoptosis and autophagy via inhibiting PI3K pathway and activating MAPK/ERK signaling in hepatocellular carcinoma cells (vol 12, pg 589, 2018)
    Wang, Jing
    Sun, Peng
    Chen, Yijun
    Yao, Hequan
    Wang, Shuzhen
    SCIENTIFIC REPORTS, 2019, 9 (1)